BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33047324)

  • 21. Indications and surgical outcome following pulmonary metastasectomy: a nationwide study.
    Vidarsdottir H; Moller PH; Jonasson JG; Pfannschmidt J; Gudbjartsson T
    Thorac Cardiovasc Surg; 2012 Sep; 60(6):383-9. PubMed ID: 22215491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades.
    Beetz O; Söffker R; Cammann S; Oldhafer F; Vondran FWR; Imkamp F; Klempnauer J; Kleine M
    Langenbecks Arch Surg; 2020 Feb; 405(1):97-106. PubMed ID: 31938833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry.
    Meagher MF; Mir MC; Autorino R; Minervini A; Kriegmair M; Maurer T; Porpiglia F; Van Bruwaene S; Linares E; Hevia V; Musquera M; Roussel E; Pavan N; Antonelli A; Zhang S; Ghali F; Patel D; Javier-Desloges J; Bradshaw A; Rubio J; Guruli G; Tracey A; Campi R; Albersen M; Furlan M; McKay RR; Derweesh IH
    Clin Genitourin Cancer; 2022 Aug; 20(4):326-333. PubMed ID: 35585014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
    de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
    Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Metastasectomy in renal cell cancer after neoadjuvant therapy with multi-tyrosine kinase inhibitors].
    Firek P; Richter S; Jaekel J; Brehmer B; Heidenreich A
    Urologe A; 2012 Mar; 51(3):398-402. PubMed ID: 22113553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome of patients with pancreatic metastases from renal cell cancer.
    Yuasa T; Inoshita N; Saiura A; Yamamoto S; Urakami S; Masuda H; Fujii Y; Fukui I; Ishikawa Y; Yonese J
    BMC Cancer; 2015 Feb; 15():46. PubMed ID: 25872621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multiple metachronous metastases of renal cell carcinoma in the pancreas. Case report and review of the literature].
    Fricke P; Schulz HU; Buhtz P; Lippert H
    Chirurg; 2000 May; 71(5):575-9. PubMed ID: 10875018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy.
    Yu X; Wang B; Li X; Lin G; Zhang C; Yang Y; Fang D; Song Y; He Z; Zhou L
    Biomed Res Int; 2015; 2015():176373. PubMed ID: 26568955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Zaid HB; Parker WP; Safdar NS; Gershman B; Erwin PJ; Murad MH; Boorjian SA; Costello BA; Thompson RH; Leibovich BC
    J Urol; 2017 Jan; 197(1):44-49. PubMed ID: 27473875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Donskov F; Xie W; Overby A; Wells JC; Fraccon AP; Sacco CS; Porta C; Stukalin I; Lee JL; Koutsoukos K; Yuasa T; Davis ID; Pezaro C; Kanesvaran R; Bjarnason GA; Sim HW; Rathi N; Kollmannsberger CK; Canil CM; Choueiri TK; Heng DYC
    Eur Urol Oncol; 2020 Aug; 3(4):530-539. PubMed ID: 32037304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.
    Hsieh PY; Hung SC; Li JR; Wang SS; Yang CK; Chen CS; Lu K; Cheng CL; Chiu KY
    Urol Oncol; 2021 Jul; 39(7):422-430. PubMed ID: 33934963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma: a retrospective cohort study.
    Dai J; He B; Zhang Y; Zhang H; Hu X; Xu L; Ni Y; Zhang X; Sun G; Zeng H; Shen P; Liu Z
    World J Urol; 2024 Apr; 42(1):259. PubMed ID: 38662226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The significance of metastasectomy in patients with metastatic renal cell carcinoma].
    Miyata H; Shinohara N; Murahashi N; Tsuchiya K; Miyajima N; Maruyama S; Abe T; Kaga K; Hirano S; Nonomura K
    Hinyokika Kiyo; 2015 Feb; 61(2):49-54. PubMed ID: 25812593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
    Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma.
    You D; Lee C; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2331-8. PubMed ID: 27553579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma.
    Malleo G; Salvia R; Maggino L; Marchegiani G; D'Angelica M; DeMatteo R; Kingham P; Pulvirenti A; Sereni E; Jarnagin WR; Bassi C; Allen PJ; Butturini G
    Ann Surg Oncol; 2021 Jun; 28(6):3100-3108. PubMed ID: 33575870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era.
    Takagi T; Fukuda H; Ishihara H; Yoshida K; Kondo T; Kobayashi H; Iizuka J; Okumi M; Ishida H; Omae K; Tanabe K
    Urol Oncol; 2020 May; 38(5):515-520. PubMed ID: 32146128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
    Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
    Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature.
    Boni A; Cochetti G; Ascani S; Del Zingaro M; Quadrini F; Paladini A; Cocca D; Mearini E
    BMC Surg; 2018 Jun; 18(1):40. PubMed ID: 29895293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and treatment of pancreatic metastasis from renal cell carcinoma].
    Chi TY; Sang XT; Mao YL; Yang ZY; Lu X; Zhong SX; Huang JF
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):793-6. PubMed ID: 19173818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.